Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.

@article{Krediet1999ClinicalOO,
  title={Clinical outcome of cephalothin versus vancomycin therapy in the treatment of coagulase-negative staphylococcal septicemia in neonates: relation to methicillin resistance and mec A gene carriage of blood isolates.},
  author={Tannette G. Krediet and Mark Edmondson Jones and Leo J. Gerards and Andr{\'e} Fleer},
  journal={Pediatrics},
  year={1999},
  volume={103 3},
  pages={E29}
}
OBJECTIVE Coagulase-negative staphylococci (CONS) are the most common causative agents in neonatal nosocomial septicemia. Because of widespread methicillin resistance among CONS, empiric therapy with vancomycin is recommended as the primary antibiotic regimen for these infections. In our unit, empiric treatment of nosocomially acquired septicemia consists… CONTINUE READING

3 Figures & Tables